← ANALYST RATINGS · TIPRANKS
Kestra Medical Technologies Ltd. (KMTS): analyst forecast and price target
Analyst consensus
Strong Buy3 Buy1 Hold0 Sell
Ratings of 4 analysts in the last 3 months · top analysts only12-month forecast
Based on 4 price targets given in the last 3 months, the average target is $29.33, the highest $30.00, the lowest $28.00. The average is +7.7% from the last price of $27.24.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $29.00 → $28.00−3.4% | Hold | +2.8% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $28.00 → $27.00−3.6% | Hold | −0.9% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $29.00 → $28.00−3.4% | Hold | +2.8% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $29.00 → $27.00−6.9% | Hold | −0.9% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $30.00 → $29.00−3.3% | Hold | +6.5% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $29.00 → $28.00−3.4% | Hold | +2.8% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $28.00 | Buy | +2.8% | Reiterated | 15.10.26on TipRanks Oct 16 05:12 | +12.3%next day −3.9% | ↗ |
| Matthew O'Brien★★★★★★★★★★#12031 · hits 41% · avg −4.5% | Piper Sandler | $30.00 | Buy | +10.1% | Reiterated | 05.10.26on TipRanks 07:56 | +2.6%next day −4.9% · 5 days −5.5% | ↗ |
| Rick Wise★★★★★★★★★★#7800 · hits 51% · avg +0.1% | Stifel Nicolaus | $30.00 | Buy | +10.1% | Reiterated | 15.09.26on TipRanks 06:30 | +5.1%next day −3.9% · 5 days +1.2% | ↗ |
| Marie Thibault★★★★★★★★★★#12343 · hits 40% · avg −9.7% | BTIG | $32.00 | Buy | +17.5% | Reiterated | 15.09.26on TipRanks 06:25 | +5.1%next day −3.9% · 5 days +1.2% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $30.00 | Buy | +10.1% | Reiterated | 14.09.26on TipRanks Sep 15 06:10 | +5.7%next day +5.1% · 5 days +1.0% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $30.00 | Buy | +10.1% | Initiated | 10.08.26on TipRanks 05:00 | +7.4%next day −1.3% · 5 days −1.8% | ↗ |
| Suraj Kalia★★★★★★★★★★#1646 · hits 50% · avg +6.8% | Oppenheimer | — | Hold | — | Initiated | 21.07.26on TipRanks Jul 23 21:35 | −5.1%next day −6.0% · 5 days +8.3% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | $22.00 → $17.00−22.7% | Hold | −37.6% | Assigned | 09.04.26on TipRanks Apr 8 16:35 | −2.5%next day −7.1% · 5 days +2.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Kestra Medical Technologies Ltd.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $30.00 at a price of $28.29 (+6.0%); now: $30.00 at $27.24 (+10.1%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 0 | 2 | 3 | 4 | 3 |
| Hold | 0 | 0 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 10.12.26 (Q2 2027, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.60 (from $-0.61 to $-0.59). Last quarter: $-0.75.
Sales
Next quarter’s sales estimate — $32M (from $32M to $32M). Last quarter: $31M.
Best top-analyst consensus in the sector · General
About Kestra Medical Technologies Ltd.
- CEO: Brian Webster
- Employees: 443
- 3933 Lake Washington Blvd NE, Kirkland, WA, 98033, US
- kestramedical.com
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.
Data from the stock’s TipRanks forecast page, read 48 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗